Durrant, L G <br/><br/>
105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses.  [electronic resource] 

 -  International journal of cancer  Jan 2000 
 - 87-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0215(20000101)85:1<87::aid-ijc16>3.0.co;2-k  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Anti-Idiotypic--administration & dosage<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD55 Antigens--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--administration & dosage<br/>Colorectal Neoplasms--immunology<br/>Dose-Response Relationship, Immunologic<br/>Epitopes, T-Lymphocyte--immunology<br/>HLA-DR Antigens--immunology<br/>Histocompatibility Testing<br/>Humans<br/>Immunization, Secondary<br/>Immunologic Memory--drug effects<br/>Immunophenotyping<br/>Leukocyte Common Antigens--biosynthesis<br/>T-Lymphocytes, Cytotoxic--immunology<br/>T-Lymphocytes, Helper-Inducer--immunology